Ryan Crandall - 07 Mar 2026 Form 4 Insider Report for MARIMED INC. (MRMD)

Role: Chief Commercial Officer
Signature: /s/ Ryan Crandall
Issuer symbol: MRMD
Transactions as of: 07 Mar 2026
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2026, 16:08:13 UTC
Previous filing: 16 Dec 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Crandall Ryan	Chief Commercial Officer	10 OCEANA WAY, 2ND FLOOR, NORWOOD	/s/ Ryan Crandall	09 Mar 2026	0002062820

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	MRMD	Common stock	Options Exercise		+12,500	+1.4%	$0.000000^*	880,015	07 Mar 2026	Direct	F1
transaction	MRMD	Common stock	Tax liability		-4,332	-0.49%	$0.0840^*	875,683	07 Mar 2026	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	MRMD	Restricted Stock Units (RSU)	Options Exercise		-12,500	-100%	$0.000000^*	0	07 Mar 2026	Common Stock, par value $.001 per share	12,500		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	RSUs convert to shares of common stock on a one-for-one basis.
F2	Reflects shares of common stock withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of RSUs.
F3	These RSUs were granted on March 7, 2023; there are no unvested RSUs remaining under this grant in accordance with the terms of an award agreement between the Issuer and the Reporting Person.